• Method of separating, proliferating and differentiating follicular stem cells and the composite product for treatment of baldness

    This patent pertains to human adipose-derived adult stem cells, which are multi-potent stem cells. To be more specific, it concerns human adipose-derived multi-potent adult stem cells, which can be maintained in its undifferentiated state through the formation of spheres and have an excellent proliferation rate, as well as the method of extracting and maintaining the said adult stem cells, the method of differentiation of the said multi-potent adult stem cells into neurocytes, adipocytes, chondrocytes, osteoblasts and insulin-secreting pancreatic beta cells, and the cellular treatment agents, containing the said adult stem cells or differentiated cells, for breast tissue formation and treatment of osteoarthritis, osteoporosis and diabetes.

    The multi-potent stem cells concerned have the ability to differentiate into osteoblasts, neurocytes, astrocytes, adipocytes, chondroblasts or insulin-secreting pancreatic beta cells, despite being adult stem cells, and thus can be used to effectively treat osteoporosis, osteoarthritis, neural diseases and diabetes and to form breast tissue. Also, spheres are formed in a culture medium containing CORM-2 culture so that they can be kept in their undifferentiated state for a long time, and they also have an outstanding proliferation rate, which makes them useful as a cellular therapeutic agent.

    Read more
  • Method of large-scale proliferation of follicular stem cells

    This patent pertains to the method of proliferating follicular stem cells at a high yield. To be more specific, it relates to the method of acquiring follicular stem cells in a large volume, using specific culture medium to which Rho-associated protein kinase (ROCK) inhibitor is added at a designated concentration level, and the culture medium used in this method.

    The culture medium for follicular stem cells concerned can lead to the proliferation of follicular stem cells, separated from scalp tissue, in an adequate amount for clinical application so that the said follicular stem cells can be used as a cellular therapeutic agent for hair growth to treat alopecia (hair loss) and atrichia.

    Read more
  • Hair growth promotion agent using autologous follicular cells and its composite product

    This patent concerns the cellular composite product with the function of promoting hair growth using scalp-derived cells with a positive or negative immunological response to CD34. To be more specific, it relates to the cellular composite product for hair growth promotion and hair loss and atrichia treatment agent, containing a certain amount of CD34-positive and –negative cells obtained by culturing the scale tissue outside the body.

    The cellular composite product for hair growth promotion obtained according to this patent is a new type of cellular therapeutic agent that is useful for hair growth promotion.

    Read more
  • Cellular therapeutic agent containing human adipose-derived multi-potent stem cells and follicular cells

    This patent pertains to the cellular therapeutic agent for inducing hair growth that contains human adipose-derived multi-potent stem cells and follicular cells. To be more specific, it relates to the cellular therapeutic agent for inducing hair growth that contains human adipose-derived adult stem cells and scalp-derived follicular cells containing CD34-positive and/or –positive cells.

    The cellular therapeutic agent for inducing hair growth obtained according to this patent effectively leads to hair growth when applied in the presence of symptoms that arise in cases where hair follicles do not form properly such asalopecia (hair loss) and atrichia.

    Read more
Do NOT follow this link or you will be banned from the site!